Previous 10 | Next 10 |
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
BDSI trades at extremely low P/E and EV/S ratios for a company that is still growing at a good clip. Management has cleared up a few concerns by finally starting the process of buying back shares and stopping the dilution that happened for so long. The largest risk remains ongoing...
4 Top Penny Stocks to Watch as August Comes to an End With the end of August in sight, many investors are looking for the best penny stocks to buy. But, it’s not as simple as a quick Google search, rather, investors need to spend time researching every penny stock on their list. ...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
BOCA RATON, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (“AzurRx” or the “Company”) ( NASDAQ: AZRX ), a company specializing in the development of targeted non-systemic, therapies for gastrointestinal (GI) diseases, today announced the...
Image source: The Motley Fool. BioDelivery Sciences International, inc (NASDAQ: BDSI) Q2 2021 Earnings Call Aug 4, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: BioDelivery Sciences International, inc (BDSI) Q2 20...
BioDelivery Sciences International, Inc. (BDSI) Q2 2021 Earnings Conference Call August 4, 2021, 8:30 AM ET Company Participants Terry Coelho - Executive Vice President and CFO Jeff Bailey - Chief Executive Officer Scott Plesha - President and CCO Conference Call Participants Brandon Folkes -...
The following slide deck was published by BioDelivery Sciences International, Inc. in conjunction with their 2021 Q2 earnings call. For further details see: BioDelivery Sciences International, Inc. 2021 Q2 - Results - Earnings Call Presentation
Total Company Net Revenue of $41.4 Million Driven by BELBUCA ® All-Time High TRx Market Share Strong Profitability with GAAP Net Income of $9.1 Million, or $0.09 per share, EBITDA Margin of 32%, and Non-GAAP Net Income of $12.5 Million, or $0.12 per Share, Drives Operat...
BioDelivery Sciences International (NASDAQ:BDSI) has entered into an agreement with Dr. Reddy’s Laboratories to acquire the U.S. and Canadian rights to ELYXYB (celecoxib oral solution). ELYXYB is the only FDA-approved ready-to-use oral solution for the acute treatment of...
News, Short Squeeze, Breakout and More Instantly...
BioDelivery Sciences International Inc. Company Name:
BDSI Stock Symbol:
NASDAQ Market:
BioDelivery Sciences International Inc. Website:
35 years industry experience including as CEO and founder of public company Stephen Squinto steps down as Chair for new role MILAN, Italy and NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage biotechnology company pioneering the developm...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...